Halozyme Therapeutics | HALO - Market Capitalization


Halozyme Therapeutics reported $9.99B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 2.33B 402M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amarin USD 341M 4M Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
Baxter International USD 11.7B 3.84B Sep/2025
Cytokinetics USD 6.58B 2.63B Sep/2025
DBV Technologies USD 274M 17M Sep/2025
Eli Lilly USD 1.05T 36.63B Feb/2026
Halozyme Therapeutics USD 8.58B 2.17B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
MannKind USD 1.65B 511M Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
United Therapeutics USD 18.96B 6B Sep/2025